An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening

Addiction

Volumn 90, Issue 7, 1995, Pages 967-970

  GEORGE, S ^a   BRAITHWAITE, R A ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC ACCURACY; DILUTION; DRUG ABUSE; DRUG SCREENING; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; RELATIVE DENSITY; URINALYSIS; URINE OSMOLALITY; URINE PH;

CREATININE; HUMANS; HYDROGEN-ION CONCENTRATION; OSMOLAR CONCENTRATION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PSYCHOTROPIC DRUGS; SPECIMEN HANDLING; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 0029074588     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1995.9079679.x     Document Type: Article

References (9)

1. Adulterants causing false negatives in illicit drug testing
2. Interference of common household chemicals in immunoassay methods for drugs of abuse
3. Evaluation of urine creatinine as a marker to identify dilute specimens being analyzed for drugs of abuse
4. Using relation between urinary cannabinoid and creatinine excretions to improve monitoring of abuser adherence to abstinence (Letter)
5. Importance of creatinine analyses of urine when screening for abused drugs
6. Mandatory guidelines for Federal workplace drug testing programs
7. Procedures for transportation workplace drug testing programmes
8. Digestion, transport and the integration of metabolism
9. Units of measurement, body fluids, composition of the body, nutrition